Balance Sheet for Eloxx Pharmaceuticals Inc. (ELOX)

$ 3.59   -0.22 (-5.77%) Volume: 117k 4:00 PM EST 25-Feb-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2018 12/2017 06/2017 06/2016 06/2015
Cash and Equivalents 48,606 24,049 33 811 3,335
Restrictable Cash 45 102 - - -
Marketable Securities - - - - -
Accounts Receivable - - - - -
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables - - - - -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 1,670 267 251 172 395
Current Deferred Income Taxes - - - - -
Other Current Assets 20 88 - - -
Total Current Assets 50,341 24,506 284 983 3,730
Land and Improvements - - - - -
Buildings and Improvement 141 53 - 10 10
Machinery, Furniture and Equipment 311 279 332 339 339
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 452 332 332 349 349
Gross Fixed Assets 452 332 332 349 349
Accumulated Depreciation (204) (54) (281) (257) (163)
Net Fixed Assets 248 278 51 93 186
Intangibles - 16,500 5,500 8,100 9,800
Cost in Excess - - - 8,762 5,781
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 129 - - - -
Total Non-Current Assets 377 278 5,561 8,243 15,818
Total Assets 50,718 24,784 5,845 9,226 19,547
Liabilities [+] in Thousands of Dollars
12/2018 12/2017 06/2017 06/2016 06/2015
Accounts Payable 747 1,520 192 90 232
Short Term Debt - - - - -
Notes Payable - 1,376 407 - -
Accrued Expenses 6,938 1,893 320 247 402
Accrued Liabilities 6,938 1,893 320 247 402
Deferred Revenues - - - - 150
Current Deferred Income Taxes - - (1,040) (680) -
Other Current Liabilities 122 (1,366) 1,855 32 (6)
Total Current Liabilities 7,807 3,423 2,774 369 779
Long Term Debt - - - - -
Deferred Income Tax - 6,600 2,200 3,240 3,920
Other Non-Current Liabilities - (6,604) (2) 1,054 2,622
Minority Interest - - - - -
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities - (4) 2,200 4,296 6,544
Total Liabilities 7,807 3,419 4,974 4,665 7,323
Preferred Shareholder's Equity - 4 2 2 2
Common Shareholder's Equity 42,911 21,361 870 4,558 12,222
Common Par 360 274 292 205 188
Additional Paid in Capital 129,825 60,047 122,402 119,983 119,218
Cumulative Translation Adjustments - - - - -
Retained Earnings (86,145) (38,960) (121,824) (115,630) (107,183)
Treasury Stock 1,129 - - - -
Other Equity Adjustments - - - - -
Total Capitalization 42,911 21,365 871 4,561 12,225
Total Equity 42,911 21,365 871 4,561 12,225
Total Liabilities & Shareholder's Equity 50,718 24,784 5,845 9,226 19,547
Cash Flow (47,185) (28,064) (6,194) (8,447) (18,903)
Working Capital 42,534 21,083 (2,490) 614 2,951
Free Cash Flow (31,602) (16,172) (1,928) (3,676) (7,604)
Invested Capital 42,911 21,361 871 4,561 12,225
Shares Outstanding - Common Class Only 35,860 27,528 1,460 1,025 938
Preferred Shares Outstanding - - 235 235 236
Total Ordinary Shares 35,860 27,528 1,460 1,025 938
Total Common Shares Outstanding 35,860 27,528 1,460 1,025 938
Treasury Shares 91 - - - -
Basic Weighted Shares Outstanding 32,437 4,976 1,161 1,016 721
Diluted Weighted Shares Outstanding 32,437 4,976 1,161 1,016 721